Brazil
Vetoquinol Saude Animal Ltda
RUA 11, QD. 07, LTS. 47/55, POLO EMPRESARIAL GOIÁS
APARECIDA DE GOIÂNIA-GO
74.985-235
Brazil
-
Press
-
Job offers
-
Investors
- Investors
- SHAREHOLDING
- AGENDA
- CORPORATE GOVERNANCE
- SUSTAINABLE DEVELOPMENT
- ETHICS AND ANTI-CORRUPTION
- FINANCIAL INFORMATION
-
SHAREHOLDER'S MEETING
- 7.1 General meeting date and venue
- 7.2 meeting notice published in the French publication for legal announcements (BALO)
- 7.3 Board's report on the compensation policy
- 7.5 Delegations of authority for capital increases at the end of the reporting period
- 7.6 Registration document (URD)
- 7.7 Statutory auditors'report on regulated agreements
- 7.8 Board's report on corporate governance
- 7.9 List of directors and offices
- 7.10 Description of the share buyback program
- 7.11 Statutory Auditors'report on the draft resolutions submitted to the meeting
- 7.12 Document request form
- 7.13 Form for voting by both lail or proxy
- 7.14 Total number of voting rights existing and the number of shares comprising the capital on the publication date of the notice mentioned in article 225-73 of the French commercial Code, specifying, as applicable the number of shares and voting rights
- 7.15 As applicable, the text and presentation of the reasons for the draft resolutions presented by shareholders
- 7.16 As applicable, the list of tiems added to the agenda by the shareholders, accompanied by comments of the Board on these items.
- 7.17 As applicable, the response of the Board to written questions submitted by the shareholders
- 7.18 Meeting notice published in the BALO at D-15
- 7.19 Video of the General Meeting
- 7.20 Results of the votes
- 7.21 Report of the General Meeting
- PUBLIC RELEASES
-
REGULATED INFORMATION
- 9.1 Annual report
- 9.2 Half year report
- 9.3 Quaterly data
- 9.4 Monthly Information on the total number of voting rights and the number of shares
- 9.5 Description of the share buyback programs
- 9.6 Permanente information
- 9.10 Information on shareholding threshold
- CONTACT SOCIETES
- LEGAL NOTICE
2024 Key figures
€539 million
2,501 people
Essential products: €328m
Lastest press releases
-
Press
-
Job offers
-
Investors
- Investors
- SHAREHOLDING
- AGENDA
- CORPORATE GOVERNANCE
- SUSTAINABLE DEVELOPMENT
- ETHICS AND ANTI-CORRUPTION
- FINANCIAL INFORMATION
-
SHAREHOLDER'S MEETING
- 7.1 General meeting date and venue
- 7.2 meeting notice published in the French publication for legal announcements (BALO)
- 7.3 Board's report on the compensation policy
- 7.5 Delegations of authority for capital increases at the end of the reporting period
- 7.6 Registration document (URD)
- 7.7 Statutory auditors'report on regulated agreements
- 7.8 Board's report on corporate governance
- 7.9 List of directors and offices
- 7.10 Description of the share buyback program
- 7.11 Statutory Auditors'report on the draft resolutions submitted to the meeting
- 7.12 Document request form
- 7.13 Form for voting by both lail or proxy
- 7.14 Total number of voting rights existing and the number of shares comprising the capital on the publication date of the notice mentioned in article 225-73 of the French commercial Code, specifying, as applicable the number of shares and voting rights
- 7.15 As applicable, the text and presentation of the reasons for the draft resolutions presented by shareholders
- 7.16 As applicable, the list of tiems added to the agenda by the shareholders, accompanied by comments of the Board on these items.
- 7.17 As applicable, the response of the Board to written questions submitted by the shareholders
- 7.18 Meeting notice published in the BALO at D-15
- 7.19 Video of the General Meeting
- 7.20 Results of the votes
- 7.21 Report of the General Meeting
- PUBLIC RELEASES
-
REGULATED INFORMATION
- 9.1 Annual report
- 9.2 Half year report
- 9.3 Quaterly data
- 9.4 Monthly Information on the total number of voting rights and the number of shares
- 9.5 Description of the share buyback programs
- 9.6 Permanente information
- 9.10 Information on shareholding threshold
- CONTACT SOCIETES
- LEGAL NOTICE
2024 Key figures
€539 million
2,501 people
Essential products: €328m
Lastest press releases
Europe
Asia
Oceania